Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older.

MLA

Ido, Keisuke, et al. “Effect of Treatment Modality and Cerebral Vasospasm Agent on Patient Outcomes after Aneurysmal Subarachnoid Hemorrhage in the Elderly Aged 75 Years and Older.” PLoS ONE, vol. 15, no. 4, Apr. 2020, pp. 1–14. EBSCOhost, https://doi.org/10.1371/journal.pone.0230953.

APA

Ido, K., Kurogi, R., Kurogi, A., Nishimura, K., Arimura, K., Nishimura, A., Ren, N., Kada, A., Matsuo, R., Onozuka, D., Hagihara, A., Takagishi, S., Yamagami, K., Takegami, M., Nohara, Y., Nakashima, N., Kamouchi, M., Date, I., Kitazono, T., & Iihara, K. (2020). Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older. PLoS ONE, 15(4), 1–14. https://doi.org/10.1371/journal.pone.0230953

Chicago

Ido, Keisuke, Ryota Kurogi, Ai Kurogi, Kunihiro Nishimura, Koichi Arimura, Ataru Nishimura, Nice Ren, et al. 2020. “Effect of Treatment Modality and Cerebral Vasospasm Agent on Patient Outcomes after Aneurysmal Subarachnoid Hemorrhage in the Elderly Aged 75 Years and Older.” PLoS ONE 15 (4): 1–14. doi:10.1371/journal.pone.0230953.